IL2 and neoplasm: By day 30, vaccination combined with IL-21 + IL-2 similarly inhibited tumor growth significantly better than vaccination alone (P < 0.0001), but produced higher statistically significant inhibition than vaccination combined with IL-2 (p = 0.0002) or with IL-21 (p = 0.0024) when compared to day 28.